Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Clin Cancer Res. 2021 Feb 26;27(11):2996–3004. doi: 10.1158/1078-0432.CCR-21-0066

Figure 3:

Figure 3:

(A) Kaplan-Meier estimates of OS; (B) PFS comparing binimetinib-treated colorectal cancer patients with tumors harboring codon 61 NRAS mutations to colorectal cancer patients with tumors harboring codon 12 or 13 NRAS mutations.